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Supplementary Tables 
Supplementary Table 1. Uptake by age (years), sex, socio-economic deprivation 
(Scottish Index of Multiple Deprivation: SIMD) and screening history 
  FOBT (95% CI) FIT (95% CI) 
Uptake     
Total 56.4% (56.3%-56.5%) 63.9% (63.8%-64%) 
 
Age group (years)     
50-54 47.3% (47.1%-47.5%) 57.5% (57.4%-57.7%) 
55-59 53.8% (53.5%-54.0%) 60.3% (60.1%-60.5%) 
60-64 59.7% (59.5%-59.9%) 66.1% (65.9%-66.3%) 
65-69 66.2% (65.9%-66.4%) 71.3% (71.1%-71.6%) 
70-74 63% (62.7%-63.2%) 69.6% (69.3%-69.8%) 
 
Sex     
Male 53.2% (53.1%-53.4%) 61.6% (61.4%-61.7%) 
Female 59.6% (59.4%-59.7%) 66.1% (66%-66.3%) 
 
SIMD     
1 - most deprived 43.3% (43.1%-43.6%) 51.7% (51.4%-51.9%) 
2 51.4% (51.2%-51.7%) 59.3% (59.1%-59.5%) 
3 57.7% (57.5%-58%) 65.2% (65.0%-65.4%) 
4 62.4% (62.2%-62.6%) 69.3% (69.1%-69.5%) 
5 - least deprived 66.1% (65.8%-66.3%) 72.5% (72.3%-72.7%) 
 
Screening history     
First round 45.8% (45.5%-46.1%) 59.1% (58.8%-59.5%) 
Participated in previous round 87.5% (87.4%-87.6%) 92.3% (92.3%-92.4%) 
Did not participate in previous    
round 38.6% (38.2%-39%) 52.9% (52.5%-53.2%) 
Never participated 8.8% (8.7%-9%) 18.9% (18.8%-19.1%) 
 
  
Supplementary Table 2. Positivity of Faecal Occult Blood Test (FOBT) and Faecal 
Immunochemical Test (FIT) by age (years), sex and socio-economic deprivation 
(Scottish Index of Multiple Deprivation: SIMD) 
  FOBT (95% CI) FIT (95% CI) 
Positivity     
Total 2.2% (2.1%-2.2%) 3.1% (3%-3.1%) 
 
Age group (years)     
50-54 1.6% (1.6%-1.7%) 2.3% (2.2%-2.4%) 
55-59 1.8% (1.7%-1.9%) 2.7% (2.6%-2.8%) 
60-64 1.8% (1.7%-1.9%) 3.1% (3%-3.2%) 
65-69 2.9% (2.8%-3%) 3.7% (3.5%-3.8%) 
70-74 3% (2.9%-3.1%) 4% (3.9%-4.2%) 
 
Sex     
Male 2.6% (2.5%-2.7%) 3.6% (3.5%-3.7%) 
Female 1.8% (1.7%-1.8%) 2.6% (2.5%-2.6%) 
 
SIMD     
1 - most deprived 3.2% (3.1%-3.4%) 4.3% (4.1%-4.4%) 
2 2.6% (2.5%-2.7%) 3.5% (3.4%-3.6%) 
3 2.1% (2.0%-2.2%) 3.0% (3.0%-3.1%) 
4 1.8% (1.7%-1.9%) 2.7% (2.6%-2.7%) 
5 - least deprived 1.5% (1.5%-1.6%) 2.4% (2.3%-2.5%) 
 
  
Supplementary Table 3. Colorectal cancer (CRC) positive predictive value (PPV) by  
age (years), sex and socio-economic deprivation (Scottish Index of Multiple  
Deprivation: SIMD) 
 
  FOBT (95% CI) FIT (95% CI) 
CRC PPV     
Total 6.4% (5.9%-6.9%) 5.2% (4.8%-5.5%) 
 
Age group (years)     
50-54 4.4% (3.5%-5.6%) 3.1% (2.5%-3.8%) 
55-59 5.2% (4.2%-6.5%) 3.9% (3.2%-4.8%) 
60-64 6.4% (5.3%-7.8%) 5% (4.3%-5.8%) 
65-69 6.7% (5.7%-7.9%) 6.4% (5.5%-7.4%) 
70-74 8.6% (7.4%-10.1%) 7.0% (6.2%-8.0%) 
Sex     
Male 6.8% (6.1%-7.5%) 5.3% (4.8%-5.8%) 
Female 5.9% (5.2%-6.7%) 5.0% (4.4%-5.5%) 
 
SIMD     
1 - most deprived 5.3% (4.3%-6.4%) 3.8% (3.1%-4.6%) 
2 5.5% (4.6%-6.7%) 4.7% (4%-5.6%) 
3 6.0% (5.0%-7.3%) 5.3% (4.6%-6.2%) 
4 6.5% (5.4%-7.8%) 6.0% (5.2%-6.9%) 
5 - least deprived 9.1% (7.7%-10.7%) 6.0% (5.2%-7.0%) 
 
 
  
Supplementary Table 4. Higher-risk (HR) adenoma positive predictive value (PPV) 
by age (years), sex and socio-economic deprivation (Scottish Index of Multiple 
Deprivation: SIMD) 
  FOBT (95% CI) FIT (95% CI) 
HR adenoma PPV     
Total 19.3% (18.5%-20.2%) 24.3% (23.6%-25.2%) 
 
Age group (years)     
50-54 16.3% (14.5%-18.3%) 20.0% (18.5%-21.6%) 
55-59 18.1% (16.2%-20.1%) 22.6% (20.9%-24.3%) 
60-64 18.5% (16.6%-20.5%) 24.8% (23.4%-26.3%) 
65-69 20.7% (19%-22.5%) 27.5% (25.8%-29.2%) 
70-74 22.3% (20.3%-24.3%) 26.2% (24.6%-27.8%) 
 
Sex     
Male 23.1% (21.9%-24.3%) 28.8% (27.8%-29.8%) 
Female 14.6% (13.5%-15.8%) 18.6% (17.6%-19.6%) 
 
SIMD     
1 - most deprived 19.7% (17.8%-21.6%) 23.5% (21.9%-25.1%) 
2 16.7% (15.1%-18.5%) 24.7% (23.2%-26.4%) 
3 19.3% (17.5%-21.3%) 24% (22.5%-25.6%) 
4 20.2% (18.4%-22.2%) 25.1% (23.5%-26.7%) 
5 - least deprived 21.3% (19.2%-23.5%) 24.2% (22.6%-25.9%) 
 
 
